Rating
Innovation
Pricing
Technology
Usability
We have discovered similar tools to what you are looking for. Check out our suggestions for similar AI tools.
Pfizer, drug companies make 'no commitments' to White House about lowering drug prices
Cheaper pharmaceuticals won’t be on shelves any time soon, says the CEO of Pfizer. That’s despite an executive order signed last month declaring a war on drug prices, which at one point President [...]
Stanford researchers will discuss their agentic 'scientists' that are on course to reshape drug discovery at VB Transform 2026
Drug discovery is notoriously inefficient. Pharmaceutical projects span years, moving from one specialized human team to the next through disconnected workflows that result in knowledge loss during ea [...]
The AI Revolution Is a Data Revolution: Why Storage Matters More Than Ever
Easy access to data and the ability to utilize it in meaningful ways have always been important, but in the era of AI, machine learning, and data analytics, it has become absolutely essential. The glo [...]
Will AI revolutionise drug development? Researchers say it depends on how it’s used
The potential of using artificial intelligence in drug discovery and development has sparked both excitement and skepticism among scientists, investors and the general public. “Artificial intelligen [...]
Google's AI drug discovery spinoff Isomorphic Labs claims major leap beyond AlphaFold 3
Isomorphic Labs, Google DeepMind's AI medicine startup, has unveiled a new system called "Isomorphic Labs Drug Design Engine" (IsoDDE) that it says doubles AlphaFold 3's accuracy f [...]
The new trailer for Clockwork Revolution is a wild, extremely steampunk ride
Two years after it was first announced, we just got an extended trailer for inXile entertainment's Clockwork Revolution at the Xbox Games Showcase, and it looks kind of incredible — and complet [...]
Alphabet's Isomorphic Labs raises $2.1 billion to scale AI drug discovery toward clinical trials
Isomorphic Labs, the AI drug research company led by DeepMind co-founder Demis Hassabis, has closed a $2.1 billion Series B round led by Thrive Capital. The funding will go toward expanding its in-hou [...]